Thomas P Miller

  • 18820 Citations
  • 57 h-Index
1978 …2021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1979 2016

  • 18820 Citations
  • 57 h-Index
  • 164 Article
  • 2 Chapter
  • 1 Letter
Filter
Article
Article
48 Citations (Scopus)

Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues

Rimsza, L. M., Wright, G., Schwartz, M., Chan, W. C., Jaffe, E. S., Gascoyne, R. D., Campo, E., Rosenwald, A., Ott, G., Cook, J. R., Tubbs, R. R., Braziel, R. M., Delabie, J., Miller, T. P. & Staudt, L. M., Jun 1 2011, In : Clinical Cancer Research. 17, 11, p. 3727-3732 6 p.

Research output: Contribution to journalArticle

Nuclease Protection Assays
Germinal Center
Lymphoma, Large B-Cell, Diffuse
Paraffin
Formaldehyde
304 Citations (Scopus)

A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest oncology group study

Fisher, R. I., Dahlberg, S., Nathwani, B. N., Banks, P. M., Miller, T. P. & Grogan, T. M., Feb 15 1995, In : Blood. 85, 4, p. 1075-1082 8 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Marginal Zone B-Cell Lymphoma
Oncology
Lymphoma
B-Lymphocytes

A clinical phase II study of ProMACE-CytaBOM [1]

Dahlberg, S., Miller, T. P. & Fisher, R. I., 1991, In : Journal of Clinical Oncology. 9, 5, p. 888 1 p.

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Drug Evaluation
Cytarabine
Bleomycin
Vincristine
22 Citations (Scopus)

A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine- tositumomab

Press, O. W., Unger, J. M., Rimsza, L. M., Friedberg, J. W., Leblanc, M., Czuczman, M. S., Kaminski, M., Braziel, R. M., Perry, C. S., Gopal, A. K., Maloney, D. G., Cheson, B. D., Dakhil, S. R., Miller, T. P. & Fisher, R. I., Dec 1 2013, In : Clinical Cancer Research. 19, 23, p. 6624-6632 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Radioimmunotherapy
Disease-Free Survival
Vincristine
Survival

Activity of esorubicin in recurrent malignant lymphoma: A southwest oncology group study

Miller, T. P., Dahlberg, S., Salmon, S. E., Williamson, S. K., Belt, R. J., Dana, B. W. & Fisher, R. I., 1991, In : Journal of Clinical Oncology. 9, 7, p. 1204-1209 6 p.

Research output: Contribution to journalArticle

Lymphoma
Non-Hodgkin's Lymphoma
Hodgkin Disease
esorubicin
Recurrence
9 Citations (Scopus)

Addition of verapamil to overcome drug resistance in multiple myeloma: Preliminary clinical observations in 10 patients

Trumper, L. H., Ho, A. D., Wulf, G., Hunstein, W., Dalton, W. S., Miller, T. P. & Salmon, S. E., 1989, In : Journal of Clinical Oncology. 7, 10, p. 1578-1579 2 p.

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Vincristine
Verapamil
Multiple Myeloma
39 Citations (Scopus)

Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment

Qi, W., Perry, C. S., Liu, X., Agarwal, A., Cooke, L. S., Persky, D. O., Chen, D., Miller, T. P. & Mahadevan, D., Apr 2013, In : Leukemia Research. 37, 4, p. 434-439 6 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Non-Hodgkin's Lymphoma
Apoptosis
Cell Line
Therapeutics
22 Citations (Scopus)

Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2

Mahadevan, D., Morales, C., Cooke, L. S., Manziello, A., Mount, D. W., Persky, D. O., Fisher, R. I., Miller, T. P. & Qi, W., Jun 3 2014, In : PLoS One. 9, 6, e95184.

Research output: Contribution to journalArticle

vincristine
Vincristine
lethal genes
mice
Tumors
151 Citations (Scopus)

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911

Press, O. W., Unger, J. M., Braziel, R. M., Maloney, D. G., Miller, T. P., LeBlanc, M., Gaynor, E. R., Rivkin, S. E. & Fisher, R. I., Sep 1 2003, In : Blood. 102, 5, p. 1606-1612 7 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Oncology
Chemotherapy
Iodine
Non-Hodgkin's Lymphoma
45 Citations (Scopus)
Vincristine
B-Cell Lymphoma
Prednisone
Non-Hodgkin's Lymphoma
Doxorubicin
107 Citations (Scopus)

A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma

Leonard, J. P., Friedberg, J. W., Younes, A., Fisher, D., Gordon, L. I., Moore, J., Czuczman, M., Miller, T. P., Stiff, P., Cheson, B. D., Forero-Torres, A., Chieffo, N., McKinney, B., Finucane, D. & Molina, A., Jul 2007, In : Annals of Oncology. 18, 7, p. 1216-1223 8 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Monoclonal Antibodies
Non-Hodgkin's Lymphoma
Lymphoma
Pharmacokinetics
24 Citations (Scopus)

A phase I/II trial of paclitaxel for non-Hodgkin's lymphoma followed by paclitaxel plus quinine in drug-resistant disease

Miller, T. P., Chase, E. M., Dorr, R. T., Dalton, W. S., Lam, K. S. & Salmon, S. E., 1998, In : Anti-Cancer Drugs. 9, 2, p. 135-140 6 p.

Research output: Contribution to journalArticle

Quinine
Paclitaxel
Non-Hodgkin's Lymphoma
Pharmaceutical Preparations
Pharmacokinetics
64 Citations (Scopus)

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study

Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A. & Miller, T. P., 1994, In : Annals of Oncology. 5, SUPPL. 2, p. 91-95 5 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Lymphoma
Survival
Treatment Failure
Combination Drug Therapy
74 Citations (Scopus)

A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213

Bernstein, S. H., Epner, E., Unger, J. M., LeBlanc, M., Cebula, E., Burack, R., Rimsza, L. M., Miller, T. P. & Fisher, R. I., Jun 2013, In : Annals of Oncology. 24, 6, p. 1587-1593 7 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cytarabine
Multicenter Studies
Febrile Neutropenia
Poisons
15 Citations (Scopus)

A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520

Puvvada, S. D., Li, H., Rimsza, L. M., Bernstein, S. H., Fisher, R. I., LeBlanc, M., Schmelz, M., Glinsmann-Gibson, B., Miller, T. P., Maddox, A. M., Friedberg, J. W., Smith, S. M. & Persky, D. O., Jan 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-11 11 p.

Research output: Contribution to journalArticle

Histocompatibility Antigens Class II
B-Cell Lymphoma
Tumor-Infiltrating Lymphocytes
T-Lymphocytes
Tumor Microenvironment
2 Citations (Scopus)

A phase II study of bisantrene in malignant lymphomas - A southwest oncology group study

Miller, T. P., Cowan, J. D., Neilan, B. A. & Jones, S. E., Jan 1986, In : Cancer Chemotherapy and Pharmacology. 16, 1, p. 67-69 3 p.

Research output: Contribution to journalArticle

bisantrene
Histology
Oncology
Lymphoma
Non-Hodgkin's Lymphoma
81 Citations (Scopus)

A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108

Stopeck, A. T., Unger, J. M., Rimsza, L. M., Bellamy, W. T., Iannone, M. E., Persky, D., Leblanc, M., Fisher, R. & Miller, T. P., 2009, In : Leukemia and Lymphoma. 50, 5, p. 728-735 8 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Vascular Endothelial Growth Factor A
Disease-Free Survival
Mantle-Cell Lymphoma
Vascular Endothelial Growth Factor Receptor
70 Citations (Scopus)

A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis

Tome, M. E., Johnson, D. B. F., Rimsza, L. M., Roberts, R. A., Grogan, T. M., Miller, T. P., Oberley, L. W. & Briehl, M. M., Nov 15 2005, In : Blood. 106, 10, p. 3594-3601 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Oxidation-Reduction
Thioredoxins
Chemotherapy
Antioxidants
11 Citations (Scopus)

A southwest oncology group perspective on the revised European-American lymphoma classification

Grogan, T. M., Miller, T. P., Fisher, R. I. & Graff, J. C., 1997, In : Hematology/Oncology Clinics of North America. 11, 5, p. 819-846 28 p.

Research output: Contribution to journalArticle

Lymphoma
Terminology
Names
Neoplasms
1 Citation (Scopus)

A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma

Grever, M. R., Benedetti, J., Balcerzak, S. P., Taylor, S. A., Miller, T. P. & Dakhil, S. R., Sep 1994, In : Investigational New Drugs. 12, 3, p. 259-261 3 p.

Research output: Contribution to journalArticle

Antineoplastic Antimetabolites
Vidarabine Phosphate
Hematologic Diseases
Sleep Stages
Sarcoma
25 Citations (Scopus)

AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas

Qi, W., Liu, X., Cooke, L. S., Persky, D. O., Miller, T. P., Squires, M. & Mahadevan, D., Jun 15 2012, In : International Journal of Cancer. 130, 12, p. 2997-3005 9 p.

Research output: Contribution to journalArticle

Aurora Kinases
docetaxel
B-Cell Lymphoma
Growth
Neoplasms
43 Citations (Scopus)

Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma

Mahadevan, D., Stejskal, A., Cooke, L. S., Manziello, A., Morales, C., Persky, D. O., Fisher, R. I., Miller, T. P. & Qi, W., Apr 15 2012, In : Clinical Cancer Research. 18, 8, p. 2210-2219 10 p.

Research output: Contribution to journalArticle

docetaxel
Vincristine
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Neoplasms
66 Citations (Scopus)

Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma

Qi, W., Cooke, L. S., Liu, X., Rimsza, L. M., Roe, D., Persky, A. M. D. O., Miller, T. P. & Mahadevan, D., Apr 1 2011, In : Biochemical Pharmacology. 81, 7, p. 881-890 10 p.

Research output: Contribution to journalArticle

docetaxel
Mantle-Cell Lymphoma
Tumors
Apoptosis
Neoplasms
180 Citations (Scopus)

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma

Stiff, P. J., Unger, J. M., Cook, J. R., Constine, L. S., Couban, S., Stewart, D. A., Shea, T. C., Porcu, P., Winter, J. N., Kahl, B. S., Miller, T. P., Tubbs, R. R., Marcellus, D., Friedberg, J. W., Barton, K. P., Mills, G. M., LeBlanc, M., Rimsza, L. M., Forman, S. J. & Fisher, R. I., 2013, In : New England Journal of Medicine. 369, 18, p. 1681-1690 10 p.

Research output: Contribution to journalArticle

Autologous Transplantation
Non-Hodgkin's Lymphoma
Transplantation
Control Groups
Disease-Free Survival
4 Citations (Scopus)

Chemohormonal therapy for advanced breast cancer with tamoxifen, adriamycin, and cyclophosphamide (TAC)

Ahmann, F. R., Jones, S. E., Moon, T. E., Hammond, N., Miller, T. P. & Durie, B. G., 1985, In : Cancer. 56, 4, p. 730-737 8 p.

Research output: Contribution to journalArticle

Tamoxifen
Doxorubicin
Cyclophosphamide
Breast Neoplasms
Estrogen Receptors
789 Citations (Scopus)

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

Miller, T. P., Dahlberg, S., Cassady, J. R., Adelstein, D. J., Perry, C. S., Grogan, T. M., LeBlanc, M., Carlin, S., Chase, E. & Fisher, R. I., Jul 2 1998, In : New England Journal of Medicine. 339, 1, p. 21-26 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Radiotherapy
Drug Therapy
Disease-Free Survival
Poisons
6 Citations (Scopus)

Chemotherapy of advanced non-small cell lung cancer - A review

Takasugi, B. J. & Miller, T. P., Sep 1984, In : Investigational New Drugs. 2, 3, p. 339-347 9 p.

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Vindesine
Vinblastine
Non-Small Cell Lung Carcinoma
Antineoplastic Agents
55 Citations (Scopus)

CHEMOTHERAPY OF LOCALISED HISTIOCYTIC LYMPHOMA

Miller, T. P. & Jones, S., Feb 17 1979, In : The Lancet. 313, 8112, p. 358-360 3 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Drug Therapy
Non-Hodgkin's Lymphoma
Doxorubicin
Disease-Free Survival
54 Citations (Scopus)

Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: A southwest oncology group study

Jones, S. E., Grozea, P. N., Miller, T. P., Van Slyck, E. J., Balcerzak, S. P., Costanzi, J. J., Morrison, F. S., Eyre, H. J., Fabian, C. J. & Dabich, L., 1985, In : Journal of Clinical Oncology. 3, 10, p. 1318-1324 7 p.

Research output: Contribution to journalArticle

Levamisole
Vincristine
Mycobacterium bovis
Prednisone
Doxorubicin
36 Citations (Scopus)

Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: A Southwest Oncology Group study

Weick, J. K., Dahlberg, S., Fisher, R. I., Dana, B., Miller, T. P., Balcerzak, S. P. & Pierce, H. I., 1991, In : Journal of Clinical Oncology. 9, 5, p. 748-753 6 p.

Research output: Contribution to journalArticle

Combination Drug Therapy
Non-Hodgkin's Lymphoma
Histology
Mucositis
Leucovorin
50 Citations (Scopus)

Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501

Velasquez, W. S., Lew, D., Grogan, T. M., Spiridonidis, C. H., Balcerzak, S. P., Dakhil, S. R., Miller, T. P., Lanier, K. S., Chapman, R. A. & Fisher, R. I., May 15 2003, In : Journal of Clinical Oncology. 21, 10, p. 1996-2003 8 p.

Research output: Contribution to journalArticle

Mitoxantrone
Non-Hodgkin's Lymphoma
Disease-Free Survival
Vincristine
Prednisone
6 Citations (Scopus)

Combined chemotherapy plus radiotherapy for treatment of early-stage intermediate- and high-grade non-Hodgkin's lymphoma.

Briggs, J. H. & Miller, T. P., Mar 2000, In : Current Oncology Reports. 2, 2, p. 176-181 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Radiotherapy
Drug Therapy
Benchmarking
Combined Modality Therapy
1873 Citations (Scopus)

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, H. M., Mize, E. M., Glick, J. H., Coltman, C. A. & Miller, T. P., Apr 8 1993, In : New England Journal of Medicine. 328, 14, p. 1002-1006 5 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Drug Therapy
Vincristine
Doxorubicin
Cyclophosphamide
35 Citations (Scopus)

Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in Stages III and IV Hodgkin's disease. A Southwest Oncology Group study

Mansfield, C. M., Fabian, C., Jones, S., Van Slyck, E. J., Grozea, P., Morrison, F., Miller, T. P., Seibert, C. & Ayyangar, K., 1990, In : Cancer. 66, 11, p. 2295-2299 5 p.

Research output: Contribution to journalArticle

Lymphography
Hodgkin Disease
Abdomen
Tomography
Laparotomy
2 Citations (Scopus)
Vincristine
Prednisone
Hodgkin Disease
Doxorubicin
Cyclophosphamide
1 Citation (Scopus)

Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer - A Southwest Oncology Group study

Collins, C., Higano, C. S., Livingston, R. B., Griffin, B. R., Keppen, M. D. & Miller, T. P., Aug 1989, In : Cancer Chemotherapy and Pharmacology. 24, 2, p. 128-132 5 p.

Research output: Contribution to journalArticle

Oncology
Chemotherapy
Small Cell Lung Carcinoma
Radiotherapy
Vincristine
45 Citations (Scopus)

Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: Relationship to HLA expression and host immunocompetence

List, A. F., Perry, C. S., Miller, T. P. & Grogan, T. M., Mar 1993, In : Leukemia. 7, 3, p. 398-403 6 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Immunocompetence
Lymphoma
T-Lymphocytes
B-Cell Lymphoma
9 Citations (Scopus)
Non-Hodgkin's Lymphoma
Histology
Therapeutics
Doxorubicin
Vincristine
80 Citations (Scopus)

Diffuse aggressive lymphoma.

Fisher, R. I., Miller, T. P. & O'Connor, O. A., 2004, In : Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. p. 221-236 16 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Mantle-Cell Lymphoma
Drug Therapy
Lymphoma, Large B-Cell, Diffuse
Standard of Care
15 Citations (Scopus)

Diffuse small cleaved-cell lymphoma: A heterogeneous disease with distinct immunobiologic subsets

Leith, C. P., Perry, C. S., Grogan, T. M., Gonzales, G., Rangel, C. S., Rybski, J. A., Matzner, M. & Miller, T. P., 1992, In : Journal of Clinical Oncology. 10, 8, p. 1259-1265 7 p.

Research output: Contribution to journalArticle

L-Lactate Dehydrogenase
Non-Hodgkin's Lymphoma
Cell Lineage
Survival
B-Lymphocytes
9 Citations (Scopus)

Directed indices for exploring gene expression data

LeBlanc, M., Kooperberg, C., Grogan, T. M. & Miller, T. P., Apr 12 2003, In : Bioinformatics. 19, 6, p. 686-693 8 p.

Research output: Contribution to journalArticle

Gene Expression Data
Gene expression
Genes
Gene
Gene Expression
67 Citations (Scopus)

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: A phase II study of the Southwest Oncology Group (SWOG 9349)

Blayney, D. W., LeBlanc, M. L., Grogan, T., Gaynor, E. R., Chapman, R. A., Spiridonidis, C. H., Taylor, S. A., Bearman, S. I., Miller, T. P. & Fisher, R. I., Jul 1 2003, In : Journal of Clinical Oncology. 21, 13, p. 2466-2473 8 p.

Research output: Contribution to journalArticle

Vincristine
Prednisone
Non-Hodgkin's Lymphoma
Doxorubicin
Cyclophosphamide
508 Citations (Scopus)

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: Detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy

Dalton, W. S., Grogan, T. M., Meltzer, P. S., Scheper, R. J., Durie, B. G. M., Taylor, C. W., Miller, T. P. & Salmon, S. E., 1989, In : Journal of Clinical Oncology. 7, 4, p. 415-424 10 p.

Research output: Contribution to journalArticle

P-Glycoprotein
Verapamil
Multiple Myeloma
Drug Resistance
Non-Hodgkin's Lymphoma
91 Citations (Scopus)

Effectiveness of first-line management strategies for stage I follicular lymphoma: Analysis of the National Lymphocare Study

Friedberg, J. W., Byrtek, M., Link, B. K., Flowers, C., Taylor, M., Hainsworth, J., Cerhan, J. R., Zelenetz, A. D., Hirata, J. & Miller, T. P., Sep 20 2012, In : Journal of Clinical Oncology. 30, 27, p. 3368-3375 8 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Disease-Free Survival
Guidelines
Therapeutics
Whole Body Imaging
314 Citations (Scopus)

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group experience

Dixon, D. O., Neilan, B., Jones, S. E., Lipschitz, D. A., Miller, T. P., Grozea, P. N. & Wilson, H. E., 1986, In : Journal of Clinical Oncology. 4, 3, p. 295-305 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Therapeutics
Age Groups
Levamisole
Survival
40 Citations (Scopus)

Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A southwest oncology group study

Miller, T. P., Chen, T. T., Coltman, C. A., O'Bryan, R. M., Vance, R. B., Weiss, G. B., Fletcher, W. S., Stephens, R. L. & Livingston, R. B., 1986, In : Journal of Clinical Oncology. 4, 4, p. 502-508 7 p.

Research output: Contribution to journalArticle

Combination Drug Therapy
Survival
Mitomycin
Vincristine
Therapeutics
29 Citations (Scopus)

Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay

Ludwig, R., Alberts, D. S., Miller, T. P. & Salmon, S. E., Apr 1984, In : Cancer Chemotherapy and Pharmacology. 12, 3, p. 135-141 7 p.

Research output: Contribution to journalArticle

Drug Evaluation
Tumors
Assays
Appointments and Schedules
Vinblastine
31 Citations (Scopus)

Examination of the follicular lymphoma international prognostic index (FLIPI) in the national lymphocare study (NLCS): A prospective US patient cohort treated predominantly in community practices

Nooka, A. K., Nabhan, C., Zhou, X., Taylor, M. D., Byrtek, M., Miller, T. P., Friedberg, J. W., Zelenetz, A. D., Link, B. K., Cerhan, J. R., Dillon, H., Sinha, R., Shenoy, P. J., Levy, D., Dawson, K., Hirata, J. H. & Flowers, C. R., Feb 2013, In : Annals of Oncology. 24, 2, p. 441-448 8 p., mds429.

Research output: Contribution to journalArticle

Follicular Lymphoma
Prospective Studies
Disease-Free Survival
Survival
Watchful Waiting
27 Citations (Scopus)
Large Cell Carcinoma
Mitomycin
Vincristine
Fluorouracil
Adenocarcinoma
11 Citations (Scopus)
Vindesine
Large Cell Carcinoma
Fluorouracil
Adenocarcinoma
Carcinoma